21st Century Approach - No average patient: A Noninvasive measuring of drug sensitivity

21st Century Approach - No average patient: A Noninvasive measuring of drug sensitivity

Joint Event on Healthcare and Health Management & Cardiology and Cardiac Surgery
August 27-28, 2018 | London, UK

Maria Kuman

Holistic Research Institute, USA

Posters & Accepted Abstracts : J Public Health Policy Plann

Abstract:

Clinical research shows that humans have different: drug, stress, and emotional sensitivity. Usually, the drug-sensitive individuals are also stress sensitive and emotionally sensitive. If so, there is no such a thing as an average patient. The dose for a low-sensitive patient would almost kill the high-sensitive one by triggering a bouquet of allergic reactions. The presently existing method for testing drug tolerance (Boston University School of Medicine) requires ingesting of the drug, which means the intolerance is detected after the harm is done. The Holiner’s test of genetic testing is complicated, time consuming, and does not have the accuracy of our method. Sensitivity could be measured with the amount of released neurotransmitters, but this would require blood drawing. Since the neurotransmitters are electrically charged, we offer electrical measurements with our sensitive patented equipment to measure the drug, stress and emotional sensitivity of patients. The drug tolerance can be tested when the drug is prescribed; it does not require ingestion, it is fast, and it is non-invasive. Based on measurements, the patients would be divided into three basic groups: low, middle, and high sensitivity and each group would be drug-treated differently. This article also explains why the mathematical description of sensitivity would require nonlinear quantum mechanics.

Biography:

E-mail:

holisticare@mariakuman.com

PDF HTML